The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.

The New York Times released an article titled, "Zantac Products Should Not Be Sold or Used, F.D.A. Warns, Citing Cancer Danger." This article highlights how FDA concluded that a potential cancer-causing contaminant can build up in the heartburn drug Zantac when stored for long periods. The FDA's investigation was prompted by Valisure's findings if high levels of NDMA in ranitidine.

View the full article via The New York Times here.